Announced Thu, 25 Jun · 17:53 IST
Trading window closed from July 1, 2026 ahead of Q1 FY27 results
Compliance View source PDF
WINDLAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.9%1-day move
₹863.00
prior close
₹863.75
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0—-0.2+0.5-0.9-0.0-0.6+1.3-0.4-3.8+1.2———
Up moveDown movePending
AI summary
Windlas Biotech has informed exchanges that its trading window will be closed from July 1, 2026, until 48 hours after the unaudited financial results for the quarter ended June 30, 2026, are made public. This is a routine SEBI insider trading compliance measure under the company's Code of Conduct. Insiders, directors, and connected persons cannot trade in the company's shares during this period.
Likely market impact
Routine regulatory filing with no direct stock price impact. Signals that Q1 FY27 results announcement is expected soon after the quarter end.